Artificial intelligence (AI) is technology that enables machines to mimic human thinking and learning, allowing them to analyze information, recognize patterns, and make decisions. For investors, AI matters because it can improve how businesses operate, create new products, or identify opportunities faster and more accurately than humans alone, potentially impacting company success and market trends.
healthcare professionalmedical
A healthcare professional is a licensed person who provides medical care, advice or treatments—such as doctors, nurses, pharmacists, therapists and similar clinicians. Investors watch their behavior because these professionals act like trusted gatekeepers whose prescribing choices, treatment recommendations and participation in studies directly affect how quickly new drugs, devices or services are adopted and how much revenue a health company can realistically earn.
hcpmedical
An HCP (healthcare professional) is a licensed medical practitioner—such as a doctor, nurse, pharmacist or clinician—who diagnoses, treats and advises patients. For investors, HCPs are important because their prescribing choices and treatment recommendations directly affect product sales and market uptake, acting like gatekeepers whose preferences and acceptance can determine a therapy’s commercial success and regulatory exposure.
data harmonizationtechnical
The process of converting and aligning information from different sources into a common format and terminology so it can be accurately compared, combined, and analyzed. For investors this matters because clean, consistent data reduces mistakes and hidden risks—like translating several languages into one so a single picture or story can be reliably read—improving valuation, performance tracking, regulatory reporting, and decision-making.
complianceregulatory
Compliance is the act of following rules, laws, and regulations set by authorities or organizations. It ensures that businesses operate legitimately and ethically, much like how a driver follows traffic laws to keep everyone safe. For investors, compliance matters because it helps ensure that companies are managing risks properly and maintaining trustworthy practices.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
SAN FRANCISCO--(BUSINESS WIRE)--
Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative medicines company, has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to connect patient and healthcare professional (HCP) experiences, enabling teams to focus on strategic and meaningful customer interactions. Building upon its existing investments with Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences and Agentforce Marketing, Novartis plans to unify engagement across marketing, sales, patient services, medical, market access, and other service stakeholders to drive more cohesive, intelligent healthcare touchpoints.
Novartis plans to roll out Salesforce’s Agentforce 360 for Life Sciences platform globally over the next five years, with the goal of radically simplifying orchestration and experiences across its teams. The platform will allow them to become more integrated around the customer, with compliance capabilities and customer insights embedded directly through AI and data harmonization.
"The expanded partnership with Novartis underscores our commitment to transforming how the life sciences industry engages with marketing, sales, and medical stakeholders," said Frank Defesche, General Manager of Life Sciences at Salesforce. "By unifying engagement on Agentforce Life Sciences, we're providing the foundation for more personal, accurate, and connected experiences. This collaboration is ultimately about getting the right therapies to the patients that need them."
Salesforce helps organizations of any size become agentic enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.com for more information.
Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.
